SEHA sets COVID-19 testing price at Dhs250 all across UAE
- Last updated: September 9, 2020 | 19:55
Rania Al Ghazzawi, Staff Reporter
The Abu Dhabi Health Services Company (SEHA) has reduced the price of COVID-19 nasal swab test from Dhs370 to Dhs250, confirming that the new price is effective in all its testing centers nationwide.
“The new price is available for all wishing to conduct the test to assure their health, while it remains free to all citizens and to their domestic workers, people of determination, the pregnant, people over fifty, people with chronic diseases, and those suffering from suspicious symptoms or contacted positive cases,” SEHA added.
It is noteworthy that there are 23 testing centers affiliating to SEHA across the UAE, working six days a week, from Saturday to Thursday, from 8am to 8pm. SEHA application provides pre-booking appointments for COVID-19 testing through selection of the nearest centre for applicants. Payment is done online via the application, SEHA added.
On the other hand, SEHA has reopened the rehabilitation department in Al Ain Hospital, resuming the provision of world class medical care to its patients.
The rehabilitation department which is located in a building separate from the main hospital facility, provides specialized services including physiotherapy, occupational therapy and speech-language pathology.
Sumaya Al Hammadi, Director of the Rehabilitation and Physiotherapy Centre, Al Ain Hospital, said: "We are pleased to provide holistic, multi-disciplinary services to the community of Al Ain through our rehabilitation department, which is equipped with the latest equipment and advanced technologies.
"The rehabilitation department cares for People of Determination, patients recovering from an illness or fracture-related surgeries, patients with learning disorders such as Attention Deficit Hyperactivity Disorder (ADHD), mental disorders and geriatric disorders. In addition, the department provides interventional treatment for children and adults diagnosed with speech and language difficulties, auditory disorders, and hearing loss."